Semaglutide Weight Loss dissolvable Tablets (Sublingual)

Absolutely. All medications are prescribed by regulated, independent prescribers. This includes clinicians registered with:

• GMC – General Medical Council (Doctors)
• NMC – Nursing and Midwifery Council (Nurse Independent Prescribers)
• HCPC – Health and Care Professions Council (e.g., Independent Prescribing Paramedics or Physiotherapists)
• GPhC – General Pharmaceutical Council (Pharmacist Independent Prescribers)
• GDC – General Dental Council (Dentist Prescribers)

Each prescriber works within their scope of competence and adheres to UK national prescribing standards, with full indemnity cover and compliance to MHRA and CQC standards.

To initiate treatment with medications such as Ozempic, Mounjaro, or Saxenda, patients are typically required to meet one of the following eligibility criteria:

• BMI ≥30 (classified as obese), or
• BMI ≥27 with weight-related health conditions (e.g., hypertension, PCOS, pre-diabetes)

These thresholds are based on clinical safety data and regulatory guidelines, as GLP-1 receptor agonists are intended for individuals at medical risk from excess weight.

However, once therapy has commenced and the patient is responding well—with documented clinical benefit and no adverse effects—continuation of treatment below these BMI thresholds is often appropriate. This is especially valid when:

• The individual is yet to reach their target BMI, health outcome, or sustainable clothing size
• The treatment is being used to maintain weight loss in the context of a holistic lifestyle approach
• There are valid cosmetic or body composition goals under continued professional supervision

This phased and ethically grounded approach ensures patients are not penalised for progress and receive consistent support in achieving and sustaining long-term health outcomes.

We offer a range of medically supervised weight management options including:

• Mounjaro (tirzepatide)
• Saxenda (liraglutide)
• Ozempic (semaglutide)
• Buccal semaglutide (a mucosal delivery option)

All medications are provided via licensed UK-based pharmacies: ARCE, NOW, Roseway Labs, and Church Pharmacy, who are regulated and reputable suppliers.

Following consultation and payment, patients receive a Weight Management Welcome Pack, which includes:

• The prescribed medication (pen/injectable or buccal form)
• Four needles (if not already supplied by the pharmacy)
• A sharps disposal box for safe needle disposal
• Welcome guidance on safe storage, use, and monitoring

Where pharmacy packages do not include needles, these are provided directly by Haus of Asthetik. Your prescriber will always be aware of the supplier’s preferences regarding needle inclusion.

Yes. With products such as Ozempic and Mounjaro, residual fluid may be visible in the pen after the final dose. This is normal and factored into the design of the drug delivery system to ensure consistent dosing.

We are aware of social media content where individuals attempt to extract and use this remaining drug.

This is strongly discouraged, unsafe, and a misuse of a regulated medical device.

❗Haus of Asthetik will not condone or support this practice.

Misuse may result in immediate cessation of further prescriptions in accordance with MHRA guidance and our duty of care to patient safety.

All medications carry potential side effects. These include:

• Nausea or vomiting
• Constipation or diarrhoea
• Headaches
• Changes in appetite

However, it’s important to understand that serious complications have primarily been reported in specific sub-groupsof the population – often those with pre-existing health issues or unsupervised self-medication.

Under clinical supervision and with careful patient selection, adverse effects are significantly reduced. Your prescriber will conduct a thorough consultation to assess your suitability and optimise your treatment plan.

Yes. These medications are not a standalone solution.

To achieve sustained weight loss, you must commit to:

• A calorie-controlled nutrition plan
• Regular physical activity
• Behavioural and lifestyle support

Your clinician may suggest further review sessions to guide your progress.

Yes. All injectable medications (Saxenda, Ozempic, Mounjaro) are licensed by the MHRA or supplied under specialist prescribing frameworks in accordance with UK law.

Buccal semaglutide, while newer in form, is sourced from licensed compounding pharmacies and supplied under medical supervision where clinically appropriate.

You should not stop or alter your dose without consulting your prescriber. Weight loss medications work gradually, and abrupt discontinuation may affect both safety and results. If you experience side effects or have concerns, please contact the clinic.

You will receive cold-chain medication, which must be:

• Stored in a fridge (2–8°C)
• Not frozen
• Transported with care to maintain temperature

Each package will include storage instructions. Improper storage may render the medication ineffective and unsafe.

Missing a dose occasionally is not uncommon. You should:

• Administer the dose as soon as you remember, if within 5 days
• If more than 5 days have passed, skip the missed dose and resume your usual schedule

Do not double dose under any circumstance.

Used needles must be placed in the sharps disposal box provided in your welcome pack. Once full:

• You may return it to the clinic
• Or dispose of it via local council sharps collection services (contact your local authority for locations)

Do not place sharps in household waste bins.

Yes. We offer follow-up consultations (virtual or in-person) to assess:

• Your clinical response
• Side effect profile
• Dose progression
• Lifestyle integration

Monitoring ensures treatment remains safe, effective, and tailored to you.

No. These medications are not addictive.

They work by mimicking or enhancing natural gut hormones involved in regulating appetite, satiety, and blood sugar. They do not contain any steroids or stimulants.

Weight loss varies by individual. If you fail to respond after a full course (typically 12–16 weeks), your prescriber may:

• Reassess for barriers (hormonal, behavioural, metabolic)
• Consider an alternative agent
• Discontinue therapy if clinically ineffective

We always aim for safe, evidence-based results, not aggressive or unsustainable weight loss.

At Haus of Ästhetik, we prioritise expertise, precision, and client satisfaction. Our treatments are carried out by highly trained practitioners, ensuring natural-looking results with a safety-first approach. We provide bespoke, medically led treatments tailored to your individual goals, so you can feel confident in the results.